526.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TMO Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$516.00
Aprire:
$523.11
Volume 24 ore:
1.99M
Relative Volume:
0.88
Capitalizzazione di mercato:
$195.70B
Reddito:
$44.56B
Utile/perdita netta:
$6.72B
Rapporto P/E:
29.69
EPS:
17.7387
Flusso di cassa netto:
$6.29B
1 W Prestazione:
+6.15%
1M Prestazione:
+11.40%
6M Prestazione:
-2.29%
1 anno Prestazione:
+23.18%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Nome
Thermo Fisher Scientific Inc
Settore
Industria
Telefono
(781) 622-1000
Indirizzo
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
526.60 | 195.70B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
194.75 | 137.82B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
589.25 | 46.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
121.87 | 34.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
327.77 | 32.18B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | DZ Bank | Buy |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-09 | Iniziato | Goldman | Buy |
| 2025-12-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-12-01 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-11 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Iniziato | William Blair | Outperform |
| 2025-07-24 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-07-11 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Downgrade | UBS | Buy → Neutral |
| 2025-01-10 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Iniziato | Scotiabank | Sector Perform |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-10-01 | Iniziato | Stephens | Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-03-18 | Ripresa | Citigroup | Neutral |
| 2024-01-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Iniziato | HSBC Securities | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-10-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-09-06 | Ripresa | Citigroup | Buy |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-07-19 | Reiterato | Robert W. Baird | Outperform |
| 2023-07-13 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Reiterato | Barclays | Overweight |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-27 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Ripresa | Barclays | Overweight |
| 2021-10-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-16 | Iniziato | The Benchmark Company | Buy |
| 2021-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-12-02 | Iniziato | Goldman | Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-14 | Iniziato | Morgan Stanley | Overweight |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-07-15 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Reiterato | Needham | Buy |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-01-31 | Reiterato | Needham | Buy |
| 2020-01-22 | Iniziato | Credit Suisse | Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-07-25 | Reiterato | Needham | Buy |
| 2019-07-16 | Downgrade | Needham | Strong Buy → Buy |
| 2019-05-30 | Iniziato | Wolfe Research | Outperform |
| 2019-05-23 | Reiterato | Needham | Strong Buy |
| 2019-04-22 | Reiterato | Needham | Strong Buy |
| 2019-04-16 | Reiterato | BofA/Merrill | Buy |
Mostra tutto
Thermo Fisher Scientific Inc Borsa (TMO) Ultime notizie
Thermo Fisher Scientific launches Applied Biosystems™ PowerFlex™ Thermal Cycler - BioSpectrum India
Ninety One UK Ltd Has $517.14 Million Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Lifted by Ninety One SA Pty Ltd - MarketBeat
Merit Financial Group LLC Buys 3,934 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Proteomics Collaboration Advances Population Health Study - Technology Networks
OpenAI Launches GPT-Rosalind AI Model Tailored for Drug Discovery and Biology Research - MLQ.ai
Lobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results? - TradingView — Track All Markets
Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows - BioPharma APAC
Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity - The Joplin Globe
Thermo Fisher Scientific Inc. $TMO Shares Purchased by KBC Group NV - MarketBeat
Lbp Am Sa Sells 56,190 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Transient Protein Expression Market Key Players | Thermo Fisher Scientific, Promega Corporation, Merck KGAA, Qiagen - openPR.com
Thermo Fisher Scientific Inc. $TMO Shares Sold by Consolidated Investment Group LLC - MarketBeat
Border to Coast Pensions Partnership Ltd Acquires 30,245 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assetmark Inc. Raises Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific (TMO) to Release Quarterly Earnings on Thursday - MarketBeat
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
Veterinary Infectious Disease Diagnostics Industry Analysis 2025–2031 | Key Players: IDEXX Laboratories, Inc., Zoetis, Thermo Fisher Scientific - industrytoday.co.uk
Transcend Capital Advisors LLC Sells 3,364 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Annex Advisory Services LLC Acquires 3,469 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study - Clinical Lab Products
Barclays Adjusts Price Target on Thermo Fisher Scientific to $625 From $650, Maintains Overweight Rating - marketscreener.com
A Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Volatility - Yahoo Finance
Third View Private Wealth LLC Invests $4.06 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities - BioSpace
Thermo Fisher Scientific Inc (TMO) Shares Surge 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand R - pharmiweb.com
Small Molecule Innovator API CDMO Market Outlook, 2026-2033Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry - Yahoo Finance UK
TD Cowen lowers Thermo Fisher stock price target on valuation reset - Investing.com
Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities - Contract Pharma
Thermo Fisher Scientific Inc. and HealthVerity Collaborate To Expand Real-World Data Capabilities - marketscreener.com
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $625 From $683, Maintains Buy Rating - marketscreener.com
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Has $21.58 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $610 From $650, Maintains Buy Rating - marketscreener.com
Castellan Group Invests $2.11 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Baillie Gifford & Co. - MarketBeat
Thermo Fisher stock may benefit following collaboration with PRECISE - MSN
Thermo Fisher Scientific introduces the Gibco CTS Compleo Fill and Finish System - SelectScience
Altfest L J & Co. Inc. Purchases 2,806 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher PRECISE SG100K Partnership Puts Valuation And Growth In Focus - Yahoo Finance
Wallace Advisory Group Reduces Stake in Thermo Fisher Scientific - National Today
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Ritholtz Wealth Management - MarketBeat
Massachusetts Financial Services Co. MA Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness? - Yahoo Finance
Factory Mutual Insurance Co. Cuts Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc Azioni (TMO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):